Next 10 |
2024-03-28 15:00:00 ET More on the markets Where This Market Is Going (Technical Analysis) SPY: 2 Opposing Forces Wall Street Lunch: Fed Not Spooked By Recent Inflation Overbought conditions flash across all market caps: Bespoke Investment Group Energ...
Insights from 11 Abstracts Highlight Key Findings Across the Oncology Care Spectrum NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, alongside research collaborators, will present key findings from 11 abstracts at the American Association for Cancer Re...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today released its 2023 Environmental, Social, and Governance (ESG) Report highlighting progress toward building a more sustainable, diverse, and equitable company that delivers exceptional customer experience and...
2024-03-18 15:30:02 ET Piper Sandler analyst issues BUY recommendation for NEO on March 18, 2024 02:00PM ET. The previous analyst recommendation was Buy. NEO was trading at $14.76 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-03-14 09:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced the company will participate in the upcoming TD Cowen 44th Annual Health Care Conference in Boston, Massachusetts. Members of NeoGenomics’ management team will participate in a fireside chat...
2024-02-21 10:06:26 ET NeoGenomics ( NASDAQ: NEO ) shares rose over 9% in morning trading on Wednesday after the cancer diagnostics firm forecast annual revenue above Wall Street estimates.... Read the full article on Seeking Alpha For further details see: NeoGenomic...
2024-02-21 08:22:42 ET Gainers: Sound Group ( SOGP ) +113% Embraces Generative AI to Unveil New AI-Powered Applications. Origin Agritech ( SEED ) +57% reports FY results CN Energy Group ( CNEY ) +41% . Energy Focus ( EF...
2024-02-20 19:20:21 ET NeoGenomics, Inc (NEO) Q4 2023 Results Conference Call February 20, 2024 04:30 PM ET Company Participants Kendra Sweeney - VP, IR Chris Smith - CEO Jeff Sherman - CFO Vishal Sikri - President, Advanced Diagnostics Warren Stone - Pre...
2024-02-20 16:28:02 ET More on NeoGenomics NeoGenomics: Progress, But A New Uncertainty NeoGenomics Q4 2023 Earnings Preview NeoGenomics ruling seen having limited impact on estimates, Needham says Seeking Alpha’s Quant Rating on NeoGenomics Hi...
News, Short Squeeze, Breakout and More Instantly...
NeoGenomics Inc. Company Name:
NEO Stock Symbol:
NASDAQ Market:
Insights from 11 Abstracts Highlight Key Findings Across the Oncology Care Spectrum NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, alongside research collaborators, will present key findings from 11 abstracts at the American Association for Cancer Re...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today released its 2023 Environmental, Social, and Governance (ESG) Report highlighting progress toward building a more sustainable, diverse, and equitable company that delivers exceptional customer experience and...
2024-03-18 15:30:02 ET Piper Sandler analyst issues BUY recommendation for NEO on March 18, 2024 02:00PM ET. The previous analyst recommendation was Buy. NEO was trading at $14.76 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...